Harris Patrice A
Known title: DirectorCIK: 0001827502
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 7, 2026
UBSI Dividend Strength Highlighted Amid Mixed Analyst Views. Recent articles focus on United Bankshares' high dividend yield and strong capital ratios, which some analysts view as positive factors. However, other reports note warning signs in the stock's recent performance. The company currently offers a 4.44% yield, which remains a key point of interest for income-focused observers despite mixed sentiment.
Transaction History
| ACHC | ▲ Buy | Grant | 6,331 | $0 | 5/6/2026 | View on chart |
| UBSI | ▲ Buy | Grant | 1,588 | $0 | 2/19/2026 | View on chart |
| ACHC | ▲ Buy | Grant | 7,032 | $0 | 5/29/2025 | View on chart |
| UBSI | ▲ Buy | Grant | 1,904 | $0 | 2/20/2025 | View on chart |
| ACHC | ▲ Buy | Grant | 2,414 | $0 | 5/23/2024 | View on chart |
| UBSI | ▲ Buy | Grant | 1,746 | $0 | 2/22/2024 | View on chart |
| ACHC | ▲ Buy | Grant | 2,137 | $0 | 10/26/2023 | View on chart |
| UBSI | ▲ Buy | Grant | 1,464 | $0 | 2/23/2023 | View on chart |
| UBSI | ▲ Buy | Grant | 1,517 | $0 | 2/22/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Acadia Healthcare Sets Q3 2026 Earnings Date
Acadia Healthcare announced the date for its third-quarter 2026 earnings release. This update provides a timeline for the next major financial report from the company. The stock is currently trading within its 52-week range of $11.43 to $35.83, with an average analyst target price of $33.79.
Acadia Healthcare Sets Q3 2026 Earnings Date. Acadia Healthcare announced the date for its third-quarter 2026 earnings release. This update provides a timeline for the next major financial report from the company. The stock is currently trading within its 52-week range of $11.43 to $35.83, with an average analyst target price of $33.79.